Helix BioPharma Corp. (TSE:HBP - Get Free Report) shares crossed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of C$0.93 and traded as high as C$0.98. Helix BioPharma shares last traded at C$0.98, with a volume of 2,551 shares.
Helix BioPharma Price Performance
The firm has a 50 day moving average price of C$0.92 and a 200 day moving average price of C$0.99. The stock has a market capitalization of C$48.25 million, a PE ratio of -0.95 and a beta of -0.84.
Helix BioPharma Company Profile
(
Get Free Report)
Helix BioPharma Corp is a clinical-stage biopharmaceutical company. It is focused on cancer drug development. The company develops therapies in the field of immuno-oncology based on its proprietary technology mainly in the areas of cancer prevention and treatment. Its pipeline candidates are Tumor Defence Breaker L-DOS47, and, V-DOS47 among others.
Further Reading
Before you consider Helix BioPharma, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Helix BioPharma wasn't on the list.
While Helix BioPharma currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 best stocks to own in Spring 2025, carefully selected for their growth potential amid market volatility. This exclusive report highlights top companies poised to thrive in uncertain economic conditions—download now to gain an investing edge.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
